A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from 14 presentations at AUA 2024, the annual meeting of ...

Prostate cancer screening could save thousands of lives a year and should be made an option for the vast majority of men, a ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...

A single round of prostate cancer screening that included a prostate-specific antigen (PSA) test, a kallikrein panel, and an MRI detected one additional high-grade cancer per 196 men and one low-grade ...

Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test ResultsLicensing Agreement ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

Patients with prostate cancer receiving hormone therapy reported greater perceived cognitive difficulties, but cognitive tests found "no conclusive evidence of a decline," a new meta-analysis found.

Add Yahoo as a preferred source to see more of our stories on Google. On Yahoo Search, searches around terms including "prostate cancer" have gone up about 150% since the royal's diagnosis was made ...